AbbVie Inc. ABBV
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · abbvie.com
AbbVie Inc. is a research-based global biopharmaceutical company focused on developing therapies for serious and complex diseases. Their portfolio includes Humira, Skyrizi, and Rinvoq (immunology), Botox (aesthetics and therapeutics), Venclexta (oncology), and treatments in neuroscience and eye care. AbbVie was spun off from Abbott Laboratories in 2013 and is headquartered in North Chicago, Illinois.
Key ratios
FreeCashFlowOnSale TTM 0.29
FreeCashFlowOnSale 2025 0.29
FreeCashFlowOnSale 2024 0.32
FreeCashFlowOnSale 2023 0.41
Recent news
AbbVie to Host Second-Quarter 2026 Earnings Conference Call
2026-06-26 · AbbVie News
AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
2026-06-08 · PR Newswire